Scientists scan brains to find the off-switch for negative thoughts in depression
NCT ID NCT06254144
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study used fMRI brain scans to understand how people with major depression can disengage from negative thinking. Researchers analyzed brain activity patterns during different thinking states in 89 participants. The goal was to identify the neural circuits involved in shifting away from negative thoughts, which could lead to better treatments for depression.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help develop brain-based tools to detect and treat negative thinking patterns in depression.
- What could go wrong
- This is an early-stage observational study with only 89 participants. Results may not apply to everyone with depression, and the findings need further validation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
89 people
The number who actually took part.
- Started
-
Jan 2024
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Individuals with major depressive disorders
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Capable of understanding and complying with protocol requirements. * Participants who are fluent and literate in English and are able to understand and provide written, informed consent and any required privacy authorization prior to the initiation of any study procedures. * Male or female, 18 to 65 years. * Current diagnosis of MDD who are currently depressed defined by the MINI. * Participants who have moderate depressive symptoms (Patient Health Questionnaire: PHQ-9 ≥ 10 or Quick Inventory of Depressive Symptomatology: QIDS-SR ≥ 11). Exclusion Criteria: * Diagnosis of Schizophrenia spectrum or other psychotic disorders. * Bipolar I Disorder. * Active suicidal ideation with a plan and intent or suicidal ideation/attempts in the past 6-12 months. * Current diagnosis of post-traumatic disorder (PTSD) defined by the MINI. * Change in the dose or prescription of medication within the 6 weeks before enrolling in the study that could affect brain functioning. * Moderate to severe substance use disorder within the last 12 months. * A positive test for drugs of abuse, including but not limited to alcohol (breath test), cocaine, marijuana, opiates, amphetamines. * Use of \> 400 mg caffeine or nicotine within the past 2 hours. Medical Conditions * History of unstable liver or renal insufficiency. * Significant and unstable cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurological, hematologic, rheumatologic, or metabolic disturbance. * Moderate to severe traumatic brain injury or neurocognitive disorders with evidence of neurological deficits. * Co-morbid medical conditions, including cardiovascular (e.g., history of acute coronary events, stroke) and neurological diseases (e.g., Parkinson's, epilepsy). * Co-morbid inflammatory disorders (e.g., rheumatoid arthritis, autoimmune disorders). * Uncontrolled or unstable medical conditions deemed risky by investigators. * Chronic or acute infectious illness (e.g., HIV, SARS-CoV-2). * Current use of hormone-containing medications (excluding contraceptives), immunosuppressive medications, non-steroid anti-inflammatory drugs, or analgesics. MRI Contraindications * Contraindications for MRI (e.g., metal fragments, cardiac pacemaker). Miscellaneous * Unwillingness or inability to complete any of the major aspects of the study protocol. * Non-correctable vision or hearing problems. * Lack of understanding of English. * BMI \> 40 or \< 18.5. * Pregnancy or breastfeeding.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depressive disorder, major are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Laureate Institute for Brain Research
Tulsa, Oklahoma, 74136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Patients helping patients: a new test for depression care
- Could a new injection keep depression at bay for longer?
- Could a single dose of a new drug boost depression relief?
- Can a new pill ease depression without Add-Ons?
- Brain scans could make TMS for depression more precise
- Can brain training help depressed young adults stop ruminating?